For those following the International AIDS conference this week, you may be interested in this story in Nature’s news section:

AIDS vaccine research becomes ‘big science’

But ‘mission-oriented’ approach has its critics.

With no vaccine to show for more than 20 years of work, the HIV-vaccine community is being forced to radically change the way it works. Funding organizations are insisting on a ‘big science’ approach involving huge data-sharing collaborations. But AIDS researchers are divided over whether such a strategy will really speed progress towards a vaccine.

Read the story here. (you will need a password)